Today's Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
Published Date: 23 Mar 2026

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

Read More
FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma
Published Date: 23 Mar 2026

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

2.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

3.

Housing aid linked to lower medical financial hardship among US renters with cancer

4.

The most precise research tools for the deadliest blood cancer have been developed.

5.

Shorter but More Intense RT: A Better Option for HNSCC?



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot